Vasodilators and inotropic agents in the treatment of congestive heart failure

Keyphrases

• Heart Failure 100%
• Congestive Heart Failure 100%
• Inotropic Agents 100%
• Vasodilator Agents 100%
• Orally Active 66%
• Vasodilator Therapy 66%
• Positive Inotropic Effect 66%
• Effective Treatment 33%
• Adjunctive Therapy 33%
• Patients with Heart Failure 33%
• Survival Time 33%
• Inotropic Therapy 33%
• Improved Survival 33%
• Diuretics 33%
• Neuroendocrine Response 33%
• Digitalis 33%
• Replacement Treatment 33%
• Direct-acting 33%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 33%
• Failure Development 33%
• Specific Situation 33%

Medicine and Dentistry

• Congestive Heart Failure 100%
• Vasodilator Agent 100%
• Inotropic Agent 100%
• Inotropism 60%
• Pathophysiology 20%
• ACE Inhibitor 20%
• Survival Time 20%
• Patient with Congestive Heart Failure 20%
• Diuretics 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Vasodilator Agent 100%
• Congestive Heart Failure 100%
• Inotropic Agent 100%
• Syndrome 33%
• Survival Time 16%
• Dipeptidyl Carboxypeptidase Inhibitor 16%
• Pathophysiology 16%
• Diuretics 16%